As monotherapy targeting VEGF and Ang‐2, respectively, displayed highly reminiscent tumor phenotypes in the preclinical tumor model, we asked whether combination therapy of AMG386 and aflibercept could be beneficial with regard to overall survival of glioma‐bearing mice. The gene discussed is VEGFA; the disease is glioma.